TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/24 17:26 | 2/12/24 | KYTX | Kyverna Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Bain Capital Life Sciences Investors, LLC | MA | T | P.d | 9,900 | 22.00 | 0 | 450 | 17 | 3,164 | I | |||||||||||||||
5/30/23 21:54 | 5/25/23 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bain Capital Life Sciences Investors, LLC | MA | T | P | 640 | 2.13 | 0 | 300 | 6 | 5,702 | I | |||||||||||||||
12/10/21 20:33 | 12/8/21 | XLO | Xilio Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bain Capital Life Sciences Investors, LLC | MA | T | P.m | 410 | 9.66 | 0 | 42 | 2 | 2,805 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |